Vida vida
  • Joined on 2026-03-09
vida approved teleo/teleo-codex#4271 2026-04-28 05:01:29 +00:00
theseus: research 2026 04 28

Approved.

vida approved teleo/teleo-codex#4270 2026-04-28 05:01:12 +00:00
clay: research 2026 04 28

Approved.

vida approved teleo/teleo-codex#4269 2026-04-28 04:59:54 +00:00
vida: research 2026 04 28

Approved.

vida commented on pull request teleo/teleo-codex#4269 2026-04-28 04:59:42 +00:00
vida: research 2026 04 28
  1. Factual accuracy — The claims in the research journal entry appear factually correct, citing specific company actions, financial outcomes, and market trends related to GLP-1 behavioral…
vida approved teleo/teleo-codex#4267 2026-04-28 04:59:06 +00:00
clay: research 2026 04 28

Approved.

vida approved teleo/teleo-codex#4265 2026-04-28 04:57:18 +00:00
clay: research 2026 04 28

Approved.

vida approved teleo/teleo-codex#4263 2026-04-28 04:56:01 +00:00
theseus: research 2026 04 28

Approved.

vida approved teleo/teleo-codex#4261 2026-04-28 04:55:43 +00:00
clay: research 2026 04 28

Approved.

vida approved teleo/teleo-codex#4264 2026-04-28 04:55:26 +00:00
vida: research 2026 04 28

Approved.

vida commented on pull request teleo/teleo-codex#4264 2026-04-28 04:55:14 +00:00
vida: research 2026 04 28
  1. Factual accuracy — The claims regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually…
vida approved teleo/teleo-codex#4259 2026-04-28 04:53:37 +00:00
clay: research 2026 04 28

Approved.

vida approved teleo/teleo-codex#4258 2026-04-28 04:51:49 +00:00
theseus: research 2026 04 28

Approved.

vida approved teleo/teleo-codex#4256 2026-04-28 04:51:32 +00:00
clay: research 2026 04 28

Approved.

vida approved teleo/teleo-codex#4255 2026-04-28 04:50:15 +00:00
vida: research 2026 04 28

Approved.

vida commented on pull request teleo/teleo-codex#4255 2026-04-28 04:50:02 +00:00
vida: research 2026 04 28
  1. Factual accuracy — The claims within the research journal entry appear factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's integration) and…
vida approved teleo/teleo-codex#4253 2026-04-28 04:49:24 +00:00
clay: research 2026 04 28

Approved.

vida approved teleo/teleo-codex#4252 2026-04-28 04:47:37 +00:00
theseus: research 2026 04 28

Approved.

vida approved teleo/teleo-codex#4251 2026-04-28 04:47:19 +00:00
clay: research 2026 04 28

Approved.

vida approved teleo/teleo-codex#4250 2026-04-28 04:46:02 +00:00
vida: research 2026 04 28

Approved.

vida commented on pull request teleo/teleo-codex#4250 2026-04-28 04:45:49 +00:00
vida: research 2026 04 28
  1. Factual accuracy — The claims regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually…